SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Jun-21 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 28-Jun-21 | Market Purchase | 2,300 | $9.00 | $20,700.00 | 100% 0 to 2.3K | (< 1%) |
24-Feb-21 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 22-Feb-21 | Option Exercise | 5,000 | $7.84 | $39,200.00 | 33% 15.21K to 20.21K | |
24-Feb-21 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 22-Feb-21 | Market Option Sale (Planned) | 5,000 | $14.72 | $73,581.50 | (25%) 20.21K to 15.21K | |
25-Jan-21 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 21-Jan-21 | Market Sale (Planned) | 6,607 | $14.00 | $92,498.00 | (30%) 21.82K to 15.21K | 1% |
12-May-20 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 11-May-20 | Sale (Planned) | 7,500 | $16.00 | $120,000.00 | (26%) 28.57K to 21.07K | |
26-Feb-20 7:52 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 24-Feb-20 | Sale (Planned) | 5,000 | $16.83 | $84,152.90 | (15%) 33.57K to 28.57K | |
27-Jan-20 4:28 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 23-Jan-20 | Sale (Planned) | 5,000 | $17.22 | $86,102.00 | (13%) 38.57K to 33.57K |